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The primary mechanism of regulation of smooth muscle contraction involves the phosphorylation of myosin catalyzed by Ca 2+ /calmodulin-dependent myosin light chain kinase. However, additional mechanisms, both Ca "-dependent and Ca "-independent, can modulate the contractile state of smooth muscle. Protein kinase C was first implicated in the regulation of smooth muscle contraction with the observation that phorbol esters induce slowly developing, sustained contractions. Protein kinase C occurs in at least four Ca"-dependent (or, /3,, £", and y) and four Ca"-independent (8, e, f, and 17) isoenzymes. Only the a, fi, e, and f isoenzymes have been identified in smooth muscle. Both classes of isoenzymes have been implicated in the regulation of smooth muscle contraction. However, the physiologically important protein substrates of protein kinase C have not yet been identified. Specific isoenzymes may be activated by different contractile agonists, and individual isoenzymes exhibit some degree of substrate specificity. Prolonged activation of protein kinase C can result in its proteolysis to the constitutively active catalytic fragment protein kinase M, which would dissociate from the sarcolemma and phosphorylate proteins such as myosin that are inaccessible to membrane-bound protein kinase C. Protein kinase M induces relaxation of demembranated smooth muscle fibers contracted at submaximal Ca 2+ concentrations. We suggest that protein kinase C plays two distinct roles in regulating smooth muscle contractility. Stimuli triggering phosphoinositide turnover or phosphatidylcholine hydrolysis induce translocation of protein kinase C (probably specific isoenzymes) to the sarcolemma, phosphorylation of protein, and a slow contraction. Prolonged association of the kinase with the membrane may lead to proteolysis and release into the cytosol of protein kinase M, resulting in myosin phosphorylation and relaxation. . Nervous or hormonal stimulation results in an increase in [Ca 2+ ], from 120-270 nM 1 -2 to 500-700 nM, 3 whereupon Ca 2+ binds to calmodulin (CaM) to form Ca, 2+ • CaM.< Ca 2+ binding induces a conformational change in CaM 5 with exposure of sites of interaction with target proteins such as the enzyme myosin light chain kinase (MLCK), 6 resulting in formation of the ternary complex Ca 4 2+ • CaM • MLCK, which represents the active form of the kinase ( Figure  1 ). The activated kinase catalyzes phosphorylation of serine 19 in each of the two 20-kd light chains (LQo) of myosin, which triggers cross-bridge cycling and the development of force at the expense of adenosine triphosphate (ATP) hydrolysis. 7 - 8 Relaxation generally occurs upon removal of Ca 2+ from the cytosol, which results in dissociation of the Ca» 2+ • CaM • MLCK complex and regeneration of the inactive MLCK apoenzyme 9 ; myosin that was phosphorylated during the contractile phase of the cycle is dephosphorylated by
In the dephosphorylated state, myosin cross-bridges stop cycling and the muscle relaxes as the cross-bridges detach from the actin filament.
It would be possible to modulate the contractile state of a smooth muscle cell by affecting any step in the pathway shown in Figure 1 . For example, [Ca 2+ ], could be altered by regulating the activity of any of the mechanisms regulating Ca 2+ movement across the sarcolemma or sarcoplasmic reticulum (SR) membrane. Alternatively, regulation could occur at any step between the release into the cytosol of activating Ca 2+ and the contractile response (e.g., the binding of Ca 2+ to CaM, the binding of Ca, 2+ • CaM to MLCK, the activity of Ca4 2+ • CaM • MLCK or MLCP, or the cyclic interactions of phosphorylated myosin heads with actin). Several mechanisms that may modulate the contractile response have been proposed based largely on the results of in vitro experiments. Many of these mechanisms involve protein phosphorylation, and one of the most important protein kinases in this context is the Ca 2+ -and phospholipid-dependent protein kinase commonly known as protein kinase C (PKC).
Signal Transduction Involving Protein Kinase C A wide range of extracellular signals (e.g., various peptide hormones, growth factors, and neurotransmitters) bind to specific receptors located in the plasma membranes of target cells, which are coupled via a guanosine triphosphate-binding protein to the enzyme phosphoinositide-specific phospholipase C (PI-PLC). Ligand occupancy of the receptor results in activation of PI-PLC, which catalyzes the hydrolysis of membrane poryphosphoinositides, in particular, phosphatidylinositol 4,5-diphosphate (PIP 2 ), to generate the two intracellular second messengers inositol 1,4,5-trisphosphate (IP 3 ) and 1,2-diacylglycerol. 13 rP 3 , a water-soluble metabolite, diffuses through the cytosol and interacts with the IP 3 receptor located in the endoplasmic reticulum (ER) membrane (the SR membrane in smooth muscle).
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The binding of IP3 to its receptor, which is also a Ca 2+ release channel, 16 ' 17 opens the channel, allowing diffusion of Ca 2+ down its concentration gradient (approximately 10 4 -fold) from the lumen of the ER (SR) to the cytosol. Diacylglycerol remains within the plasma membrane due to its lipophilic character and functions in the activation of PKC. 18 -20 PKC is a widely distributed protein serine/threonine kinase with broad substrate specificity. The brain enzyme has been most extensively studied although the kinase has also been isolated from several other tissues including smooth muscle. 21 ' 22 We purified the enzyme (probably a mixture of a and p isoenzymes) from chicken gizzard smooth muscle and found its properties to be similar to those of the enzyme isolated from brain and other sources. 22 It is therefore a suitable example to describe some of the more important properties of PKC. The smooth muscle enzyme exhibits a molecular weight of approximately 80 kd by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and exists as a monomer under native conditions. Lysine-rich calf thymus histone (histone type III-S) is commonly used as a convenient substrate of PKC for in vitro characterization, although it should be noted that the kinetic and regulatory properties of the enzyme can vary quite markedly with the choice of substrate 23 " 23 and some PKC isoenzymes (see below) phosphorylate histone type III-S very poorly or not at all. 26 " 28 Synthetic peptide substrates are routinely used to assay these isoenzymes (see below). Phosphorylation of histone type III-S by gizzard PKC is strongly dependent on Ca 2+ , phospholipid (L-a-phosphatidyl-L-serine is normally used in vitro), and diacylglycerol. 22 Using the mixed micellar assay, 29 which is thought to reflect the native environment of the enzyme more accurately than does the liposomal assay, 30 we demonstrated 22 that the gizzard enzyme has an absolute requirement for phosphatidylserine and diacylgh/cerol, and half-maximal activation was observed at approximately 0. 5 ; this may be an unregulated form of the native kinase or a constitutively active proteoh/tic fragment of PKC released from the plasma membrane on digestion with calpain, the Ca 2+ -activated neutral thiol protease (see below).
Before discussing the putative roles of PKC in the regulation of smooth muscle contraction, it is useful to review the kinase's more important structural and regulatory properties.
Domain Structure and Regulation of Protein
Kinase C PKC is actually a family of at least eight isoenzymes. The kinase was originally isolated as a protease-activated serine/threonine protein kinase, 45 but it was later shown that the native enzyme could be activated by Ca 2+ , phospholipid, and diacylglycerol and thereby provided an important missing link in signal transduction pathways involving phosphoinositide turnover.
46 PKC was first shown to exist as multiple isoenzymes by hydroxyapatite chromatography, which separated the brain enzyme into three discrete peaks denoted types I, II, and III (now more commonly referred to as y, f), and a, respectively) in order of their elution from the column. 47 Molecular cloning verified that these were indeed isoenzymes and revealed that there are actually two forms of jj, ft, and ftj, which are derived from the same gene by alternative splicing.
48
- 49 These four isoenzymes all require Ca 2+ , phospholipid, and diacylglycerol for activity, although they exhibit differences with respect to their dependence on these cofactors as well as their kinetic properties and substrate specificities. Figure 2 compares the domain structures of the group A and B PKCs. Comparison of the amino acid sequences of group A isoenzymes indicates that the molecule could be divided into five variable (V1-V5) and four constant (C1-C4) regions. V3 contains a proteasesensitive hinge region 54 ; specific cleavage in this region allows the separation of the amino terminal regulatory domain from the carboxy terminal catalytic domain. 54 ' 55 The regulatory domain contains the binding sites for Ca 2+ , phospholipid, and diacylglycerol (or phorbol ester), and the catalytic domain contains the ATP-binding site, with the characteristic GXGXXGX 16 _ a K sequence, 55 and the active site. The isolated catalytic domain, often referred to as PKM, 45 is constitutively active.
The Cl region contains a sequence (RKGALRQK in group A PKCs) that resembles the sequences around phosphorylatable serine or threonine residues in PKC substrates, particularly with respect to the distribution of basic amino acids, except that alanine replaces the serine or threonine. This is referred to as a pseudosubstrate sequence and has been postulated to explain the mechanism of regulation of the kinase. 57 In the absence of cofactors, the pseudosubstrate domain will be bound to the active site, preventing access of the protein substrate and explaining the lack of activity under these conditions. Binding of Ca 2+ , phospholipid, and diacylglycerol then induces a conformational change 54 -58 -39 in the kinase, with removal of the pseudosubstrate domain from the active site allowing substrate entry and catalysis to occur. In support of this proposed mechanism, an antipeptide antibody to the pseudosubstrate domain completely activated PKC in the absence of cofactors. 60 Furthermore, site-specific mutagenesis of E for A in the pseudosubstrate domain of PKC-a resulted in a substantial increase in effector-independent kinase activity compared with wild-type PKC-a. 61 Synthetic peptides containing the pseudosubstrate sequence act as competitive inhibitors of PKC with respect to protein substrate 57 and are useful tools to investigate the involvement of PKC in specific cellular responses since they are much less potent toward other protein kinases. Proteoh/tic cleavage in the V3 region of PKC removes the pseudosubstrate domain and generates the constitutively active carboxy terminal fragment PKM, 45 which is also a useful experimental tool.
The Cl region also contains two cysteine-rich zinc finger sequences, O^C X^O^C X T C X T C . Zinc fingers have been identified in several DNA-binding proteins, but the relevance of these structures in PKC is unclear. However, PKC activity is affected by Zn 67 This conclusion is supported by the properties of group B PKCs (see below). The cysteine-rich sequences each contain a highly conserved amino acid triplet (VHK, IHK, or VHR) that may be involved in phospholipid binding since the catalytic site of phospholipase A 2 also contains this triplet. 68 The diacylglycerol-binding sites are probably also located in the Cl region; phorbol ester tumor promoters can substitute for diacylglycerol in PKC activation and do so by binding directly to the kinase at the diacylglycerol-binding sites (structural models of phorbol ester molecules reveal them to contain a diacylglycerol-like structure). 35 71 The domain structures of group B PKCs are quite similar to those of group A isoenzymes with the notable exception that the C2 region is lacking (Figure 2 ). When expressed in COS cells (an SV40-transformed simian cell line) or in insect cells using the baculovirus expression system, group B isoenzymes require phospholipid and diacylglycerol for activity but are independent of Ca 2+ 26-2W2,72 M o r e recently some of the group B isoenzymes have been isolated from various tissues, and these isoenzymes' activities are also Ca 2+ -indepen- dent. 73 -76 These properties are consistent with the conclusion noted above that the C2 region in group A PKCs contains the Ca 2+ -binding site (or sites). It should be noted, however, that characterization of PKC-e purified from rabbit brain showed that Ca 2+ has a complex effect on the kinase activity of this isoenzyme, with both positive and negative effects depending on the substrate and phospholipid used in the assay. 75 PKC-a and -B isoenzymes have been identified in smooth muscle (e.g., rat uterus 77 ); the y isoenzyme is central nervous system-specific and therefore not expressed in smooth muscle. We have used isoenzymespecific antibodies in Western blotting experiments to examine the expression of group B PKCs in ferret aortic smooth muscle ( Figure 3) ; PKC-e and PKC-£ are clearly expressed in this tissue, but neither PKC-5 nor PKC-77 was detected under conditions that gave clear signals from brain and lung, respectively (J.E. Andrea and M.P. Walsh, unpublished observation). Two immunoreactive bands were recognized by both anti-PKC-e (M, approximately 90 and 94 kd) and anti-PKC-£ (M, approximately 72 and 76 kd) (Figure 3 ) and may result from partial autophosphorylation as shown, for example, for rabbit brain PKC-e. 75 Autophosphorylation of PKC is a well-known phenomenon, 78 although its functional effects are unclear. Alternatively, these doublet bands may be due to phosphorylation by a different kinase. Doublets have also been observed for PKC-5 and -e isolated from rat brain, and in each case the higher M, band disappeared after phosphatase treatment. 74 -76 It will be of great interest to determine the functional effects of such phosphorylations.
Protein Kinase C in Smooth Muscle Contraction
Many examples of phorbol ester-induced contractions, particularly of vascular smooth muscle, have been reported in the literature (e.g., References 32 and 79-81). These are typically slowly developing, sustained contractions. As alluded to earlier, the contractile response could result from direct or indirect effects of PKC at any one or more steps in the excitationcontraction coupling pathway, and evidence has accumulated indicative of several possible sites of action of PKC. Activation of PKC could result in an increase in [Ca^L via an action on any of the mechanisms involved in Ca movement across the sarcolemmal or SR membranes. For example, phorbol ester-induced contractions of rabbit thoracic aorta and porcine carotid artery were accompanied by an elevation of [ 2+ channels has been reported; however, the rabbit skeletal muscle dihydropyridine receptor has been shown to be phosphorylated in vitro by PKC. 84 The activity of L-type Ca 2+ channels in A7r5 cells (an embryonic rat aortic smooth muscle cell line) were strongly depressed by synthetic diacylglycerols or phorbol esters 85 ; however, this would tend to lower rather than raise [Ca 2+ ]j. On the other hand, the synthetic diacylglycerol diC:8 activated a high-threshold, slowly inactivating Ca 2+ current in toad stomach smooth muscle cells, 86 suggesting that PKC can indeed augment Ca 2+ influx in this cell type at least. Similarly, although the smooth muscle IP 3 receptor has not been examined in this context, the brain IP 3 receptor in reconstituted lipid vesicles was stoichiometrically phosphorylated by PKC, although the effect of phosphorylation was not investigated. 87 Treatment of bovine aortic microsomes with PKC enhanced Ca 2+ uptake, and the purified sarcolemmal Ca 2+ -ATPase was stimulated by PKC. 88 Similarly, the Na + -Ca 2+ exchanger in A7r5 cells was shown to be activated by phorbol ester. 89 95 have been identified as PKC substrates in vitro. Gizzard myosin is phosphorylated by PKC at serine 1, serine 2, and threonine 9 of LCa,. Such phosphorylation alone has no effect on the enzymatic properties of myosin 96 or on the rate of movement of myosin-coated beads over an organized substratum of actin using the Nitella-based in vitro motility assay. 97 On the other hand, PKC-catalyzed phosphorylation reduces by approximately 50% the actin-activated Mg 2+ -ATPase activity of myosin previously phosphorylated at serine 19 by MLCK 96 but has no effect on the velocity of myosin-coated beads along actin cables. 97 Studies with intact and permeabilized smooth muscle fibers and cultured cells, however, do not support a physiological role for PKC-catalyzed myosin phosphorylation. For example, phorbol ester treatment of bovine tracheal, 98 rabbit aortic, 99 and porcine carotid arterial 100 smooth muscle fibers resulted in low levels of phosphorylation of serine 19 (the MLCK site) and serine 1 and/or serine 2 (PKC sites); threonine 9, the other site phosphorylated by PKC in vitro, was not phosphorylated. The absence of threonine 9 phosphorylation in these intact fiber experiments may be due to the action of phosphatases that rapidly dephosphorylate threonine 9. 101 It is unknown what effect, if any, lack of phosphorylation specifically of threonine 9 would have on the actin-activated myosin Mg J+ -ATPase. Agonists such as carbachol or phenylephrine, which induce phosphoinositide turnover and the production of diacylgrycerol, did not cause phosphorylation at any of the PKC sites in myosin, but only at serine 19 with some phosphorylation at threonine 18 98 -99 (MLCK at high concentrations can phosphorylate threonine 18 in addition to serine 19 in vitro 102 ). Treatment of permeabilized porcine carotid arterial fibers with PKC in the presence of oleic acid at pCa 8 (which produces an activated form of PKC) resulted in phosphorylation of LCa) at serine residues distinct from serine 19 but no development of force. 100 In the same preparation, maximal contraction elicited by serine 19 phosphorylation at pCa 4.7 was unaffected by PKC and oleic acid.
Gizzard MLCK is also phosphorylated by PKC (at two sites), which leads to a reduced affinity of MLCK for Ca, 2+ • CaM. 9495 However, analysis of MLCK phosphorylation in phosphorus-32-labeled bovine trachealis muscle treated with carbachol or PDBu led to the conclusion that PKC does not affect contractility by phosphorylating MLCK. 103 It seems clear therefore that contractions elicited by agonists that trigger phosphoinositide turnover do not involve PKC-catalyzed phosphorylation of either myosin or MLCK. Indeed, the in vitro effects of LCm and MLCK phosphorylation by PKC would be consistent with a relaxant rather than a contractile response. There is some evidence supportive of a relaxant effect of PKC in skinned fiber preparations. Addition of PKC (activated by a phorbol ester and phosphatidylserine) to skinned smooth muscle fibers that were maximally contracted with Ca 2+ induced relaxation concomitant with LC20 phosphorylation. 104 We investigated this mechanism using skinned (demembranated) chicken gizzard fibers and the constitutively active catalytic fragment of PKC PKM. 103 PKM attenuated a submaximal contraction that was accompanied by a reduction in the rate of ATP hydrolysis in the fiber and phosphorylation of LC20 at the PKC sites (serine 1, serine 2, and threonine 9). Several other proteins were phosphorylated in the presence of PKM; however, the facts that the same sites in LCa were phosphorylated in the skinned fibers as in purified myosin and that both resulted in decreased ATPase activity, suggests that LCa, phosphorylation is probably responsible for the observed relaxant effect of PKM.
As discussed earlier, PKC activation often involves its translocation from cytosol to plasma membrane, and this has been demonstrated in intact vascular smooth muscle strips 32 and in single cells.
33
- 106 It is unlikely that membrane-associated PKC would have access to myosin, consistent with the lack of PKC-catalyzed LCai phosphorylation in intact fibers stimulated with agonists known to activate PKC. 98 - 100 However, in several intact cell systems, proteolysis of membrane-associated PKC by calpain 107 to generate PKM has been reported. 44108 -116 Further degradation to inactive fragments may involve a neutral serine protease. 114 This mechanism provides the basis for downregulation of PKC in intact cells treated for prolonged periods with phorbol esters. PKM is an intermediate in this process. Since PKM lacks the amino terminal domain responsible for its association with the membrane, it will diffuse into the cytosol and gain access to a distinct set of protein substrates including myosin (Figure 4 ). We suggest, therefore, that PKC may have two distinct roles with respect to smooth muscle contraction. Translocation of PKC to the sarcolemma in response to a|-adrenergic or muscarinic cholinergic stimulation, for example, results in phosphorylation of a protein (or proteins) other than myosin and a slow, sustained contraction. Prolonged association of PKC with the sarcolemma can result in proteolysis to release PKM, which could then diffuse through the cytosol and phosphorylate myosin at the PKC-specific sites, causing a reduction in actomyosin ATPase activity and relaxation of the muscle or inhibition of contraction in response to appropriate agonists. Dual actions of phorbol esters on the mechanical response of smooth muscle fibers have indeed been observed. For example, phorbol ester had no effect on rat vas deferens or guinea pig ileum but enhanced the norepinephrine-induced contraction of vas deferens and blocked the oxotremorine-, histamine-, bradykinin-, and serotonin-induced contractions of the ileal smooth muscle. 117 Furthermore, phorbol esters produced a concentration-dependent, reversible relaxation of resting tension in guinea pig tracheal rings. 118 Finally, 12-o-tetradecanoylphorbol 13-acetate had dual effects on the K + -induced contraction of rabbit mesenteric artery: initial enhancement followed by inhibition during long exposure. 119 In summary, the fact that phorbol esters induce slow, sustained contractions in many smooth muscles, includ-
ing vascular smooth muscle, suggests that this response is mediated by PKC. A great deal of effort has been devoted to identifying the substrate (or substrates) of PKC that are involved in the contractile responses. The weight of evidence is against either myosin or MLCK being involved, as discussed earlier. On the other hand, PKC-catalyzed phosphorylation of proteins responsible for the movement of Ca 2+ across the sarcolemma or SR membrane, resulting in an increase in [Ca 2+ ],, is probably of importance, at least in specific smooth muscle cell types. For instances of phorbol ester-induced contractions of vascular smooth muscle that do not involve an increase in [Ca 2+ ]| or LQo phosphorylation, it is necessary to invoke other PKC substrates, and several candidates have been proposed based largely on twodimensional gel electrophoresis of proteins from phosphorus-32-labeled tissue treated with phorbol esters or various agonists (see, e.g., References 120 and 121) and in vitro phosphorylation of smooth muscle proteins by purified PKC. For example, the intermediate filament proteins desmin and synemin are phosphorylated in bovine trachealis muscle treated with carbachol, but the functional significance of these phosphorylations is unknown. 120 The thin filament-associated proteins caldesmon 122 and calponin' 23 have both been implicated in the regulation of smooth muscle contraction, and both are phosphorylated in vitro by PKC.
Caldesmon is a major smooth muscle protein, occurring as two isoforms of 88,743 d and 86,974 d, 124125 with an elongated structure (74 nm longxl.9 nm wide 126 ) that can cross-link actin and myosin filaments via a carboxy terminal actin-binding site and an amino terminal myosin-binding site. 127 The isolated protein inhibits the actin-activated myosin Mg 2+ -ATPase, suggesting a possible role in regulation of smooth muscle contraction. 128 Caldesmon is a substrate in vitro of several protein kinases including PKC. 129 Phosphorylation by PKC occurs at sites within the carboxy terminal actinbinding domain, which reduces both binding to actin and inhibition of the actomyosin ATPase. Although caldesmon phosphorylation has been observed in intact smooth muscle fiber preparations, phosphopeptide mapping of immunoprecipitated caldesmon indicates that the responsible kinase is not PKC. 130 Calponin is a smooth muscle-specific protein with at least two isoforms of 32,333 d and 28,127 d 131 that has also been implicated in the regulation of smooth muscle contraction. 132 Calponin is localized on the thin filament, and the purified protein inhibits actin-activated myosin Mg 2+ -ATPase activity. The isolated protein is phosphorylated by two protein kinases, PKC and Ca 2+ /CaMdependent protein kinase II, and phosphorylation by either kinase results in loss of actin binding and the ability to inhibit actomyosin ATPase. 132 Although Barariy et al 133 did not observe calponin phosphorylation in intact porcine carotid arterial smooth muscle, we have detected calponin phosphorylation in intact canine tracheal 134 and toad stomach (S J. Winder and M.P. Walsh, unpublished observation) smooth muscles. On the basis of in vitro binding and regulatory properties of calponin and the effects of phosphorylation, we proposed a model to explain the role of calponin and its phosphorylation/ dephosphorylation in modulation of the contractile properties of smooth muscle. 7 Evaluation of the importance of PKC-catalyzed phosphorylation of calponin in intact muscle requires further experimentation.
An interesting recent report 135 implicated the low-Af r heat shock protein hsp27 in PKC-mediated contraction of rabbit rectosigmoid cells; sustained contraction of these isolated cells in response to bombesin or exogenous PKC was blocked by preincubation of the permeabilized cells with monoclonal antibodies to hsp27.
Recent evidence obtained in collaboration with Dr. Kathleen Morgan of Harvard University suggests that Ca 2+ -independent isoenzymes of PKC may also be involved in regulation of smooth muscle contraction. Isolated ferret aortic smooth muscle cells permeabilized with saponin retained receptor coupling, that is, the ability to contract in response to a-adrenergic stimulation. At pCa 7.0, phenylephrine elicited significant force development, suggesting Ca 2+ sensitization of the contractile response. 136 However, the phenylephrine-induced contraction was retained at very low free [Ca 2+ ] (pCa 8.6 was the lowest used), suggesting that phenyl- ephrine triggers a Ca 2+ -independent pathway resulting in contraction. The phenylephrine response was reversed by phentolamine, confirming its action via a-adrenergic receptors. PKM at pCa 7 elicited a contraction comparable to the phenylephrine-induced contraction, and both PKM-and phenylephrine-induced contractions were reversed or blocked by the pseudosubstrate inhibitor peptide of PKC (RFARKGALRQKNV).
A physiological contraction in response to phenylephrine therefore probably results from activation of both MLCK and PKC ( Figure 5) . Coupling of the o-adrenergic receptor to Pl-PLC generates IP 3 and diacylglycerol resulting, respectively, in Ca 2+ release from the SR and activation of PKC. Ca 2+ release will activate MLCK and trigger cross-bridge cycling via the phosphorylation of myosin. Both Ca 2+ -dependent and Ca 2+ -independent PKC isoenzymes will be activated, resulting in phosphorylation of substrate protein (or proteins) yet to be identified and enhanced contraction. 138 In support of such a mechanism, maximal Ca 2+ -activated force in saponin-permeabilized single ferret aortic smooth muscle cells was partially inhibited by a bovine brain protein inhibitor of PKC, but the Ca 2+ sensitivity of force development was unaffected. 139 The involvement of Ca 2+ -independent PKC isoenzymes in the contractile response raises the possibility that some contractile agonists may act specifically through this pathway. If the effector enzyme is phosphatidylcholine-specific phospholipase C or D (the latter in conjunction with phosphatidate phosphohydrolase), only a single second messenger (diacylglycerol) will be generated, resulting in specific activation of group B PKC isoenzymes. 137 ' 140 In the absence of a [Ca 2+ ] transient, PKC-catalyzed phosphorylation (or phosphorylations) triggers the contractile response ( Figure 5 ).
Recent results also suggest the involvement of Ca 2+ -independent PKC in oxytocin-induced contractions of rat uterine smooth muscle in the absence of extracellular Ca 2+ . Such contractions occurred without a change in [Ca 2+ ]i M1 and in the absence of myosin LQo phosphorylation 142 ; they were, however, inhibited by the selective PKC inhibitors staurosporine and H-7. 143 Furthermore, the Ca 2+ -independent contraction was potentiated by pretreatment with the diacylglycerol kinase inhibitor R59022, which causes diacylglycerol to accumulate, and downregulation of PKC diminished th& contractile response to oxytocin in the absence of extracellular Ca 2 *. 77 Studies with the interferon a-sensitive human lymphoblastoid Daudi cell line support specific cellular roles for Ca 2+ -independent PKC isoenzymes. 144 Treatment of Daudi cells with interferon a induced a rapid and transient increase in the cellular diacylglycerol concentration without inositol phospholipid turnover or an increase in [Ca 2+ ];. Furthermore, interferon a caused activation (autophosphorylation) of PKC-e without affecting PKC-a (these were the only two PKC isoenzymes detected in these cells).
A priority for future research will be the characterization of PKC isoenzymes and their substrates in different smooth muscle tissues and, most importantly, evaluation of their respective roles in regulation of contractile properties. 
